READOUT · 08 / ABOUT
About This BPC-157 TB-500 Editorial Project
An independent reading of the Wolverine blend literature, graded by evidence class. We summarize research; we do not practice medicine or sell anything.
What this site is
Prescribed Wolverine is an independent editorial project that publishes summaries of the peer-reviewed research literature on the BPC-157 TB-500 blend. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site is built as a status board because the blend is, fundamentally, a grading problem. The single-compound findings are established — a transected rat Achilles tendon healed under BPC-157 [1], a crystal structure that pinned down how Thymosin Beta-4 sequesters actin [3]. The combination has no controlled trial [6]. A console that posts the strength of each claim next to the claim itself is the honest way to present a literature that is strong in parts and silent in others.
Why "Prescribed" is editorial framing
The word "Prescribed" in this site's name is a position the publisher occupies relative to the literature and the access record — not a claim about services we offer. We do not prescribe anything. We do not consult, diagnose, treat, or fill orders, and there are no doctors, pharmacists or clinical staff behind this site.
What "Prescribed" signals here is the access register: the regulatory question of how a compound like this is — or is not — made available through the lawful 503A and 503B compounding framework, which we cover as general information on the Wolverine legal status and 503A compounding page. That page reports present-tense FDA facts and the scheduled review, and it gives no dosing, names no vendor, and is not medical or legal advice.
How we grade
Every claim on this site carries an evidence grade and a citation. "Established" marks a citation-confirmed single-compound finding the literature actually supports [1][2][3][4]. "Preclinical" marks animal-only, in-vitro, or single-compound-extrapolation findings. "No human data" marks the blend-level gaps — the absence of a controlled combination trial and of validated blend pharmacokinetics [6][9]. "Regulatory" marks the FDA 503A and WADA facts [5][11]. We grade conservatively: where a finding is for one peptide alone or for full-length Thymosin Beta-4 rather than the TB-500 heptapeptide, we say so [4][5]. The aim is a reader who finishes the site knowing exactly what is shown, what is extrapolated, and what is unknown.